|
1
|
Rodriguez-Paredes M and Esteller M: Cancer
epigenetics reaches mainstream oncology. Nat Med. 17:330–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fraga MF, Ballestar E, Villar-Garea A, et
al: Loss of acetylation at Lys16 and trimethylation at Lys20 of
histone H4 is a common hallmark of human cancer. Nat Genet.
37:391–400. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kelly TK, De Carvalho DD and Jones PA:
Epigenetic modifications as therapeutic targets. Nat Biotechnol.
28:1069–1078. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki S, Asamoto M, Tsujimura K and
Shirai T: Specific differences in gene expression profile revealed
by cDNA microarray analysis of glutathione S-transferase placental
form (GST-P) immunohistochemically positive rat liver foci and
surrounding tissue. Carcinogenesis. 25:439–443. 2004. View Article : Google Scholar
|
|
5
|
Osada S, Naganawa A, Misonou M, et al:
Altered gene expression of transcriptional regulatory factors in
tumor marker-positive cells during chemically induced
hepatocarcinogenesis. Toxicol Lett. 167:106–113. 2006. View Article : Google Scholar
|
|
6
|
Suzuki S, Takeshita K, Asamoto M, et al:
High mobility group box associated with cell proliferation appears
to play an important role in hepatocellular carcinogenesis in rats
and humans. Toxicology. 255:160–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ohta K, Ohigashi M, Naganawa A, et al:
Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK
and induces tumour marker gene expression during
hepatocarcinogenesis. Biochem J. 402:559–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yura T, Hashizume H, Suzuki E, Imagawa M
and Osada S: Promotion of anchorage-independent growth by
cytoplasmic and nuclear histone deacetylase 9. J Health Sci.
56:581–588. 2010. View Article : Google Scholar
|
|
9
|
Hashizume H, Gomita U, Imagawa M and Osada
S: Histone methyltransferase PR-Set7 and histone variant H2A.Z,
induced during hepatocarcinogenesis, repress the promoter activity
of the tumor marker gene and the Ras-induced colony formation
activity. J Health Sci. 57:264–273. 2011. View Article : Google Scholar
|
|
10
|
Morimura S, Suzuki T, Hochi S, et al:
Trans-activation of glutathione transferase P gene during chemical
hepatocarcinogenesis of the rat. Proc Natl Acad Sci USA.
90:2065–2068. 1993. View Article : Google Scholar
|
|
11
|
Sakai M and Muramatsu M: Regulation of
glutathione transferase P: a tumor marker of hepatocarcinogenesis.
Biochem Biophys Res Commun. 357:575–578. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen D, Ma H, Hong H, et al: Regulation of
transcription by a protein methyltransferase. Science.
284:2174–2177. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu W, Chen H, Du K, et al: A
transcriptional switch mediated by cofactor methylation. Science.
294:2507–2511. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Koh SS, Li H, Lee YH, Widelitz RB, Chuong
CM and Stallcup MR: Synergistic coactivator function by
coactivator-associated arginine methyltransferase (CARM) 1 and
β-catenin with two different classes of DNA-binding transcriptional
activators. J Biol Chem. 277:26031–26035. 2002.PubMed/NCBI
|
|
15
|
Covic M, Hassa PO, Saccani S, et al:
Arginine methyltransferase CARM1 is a promoter-specific regulator
of NF-κB-dependent gene expression. EMBO J. 24:85–96. 2005.
|
|
16
|
Ma H, Baumann CT, Li H, et al:
Hormone-dependent, CARM1-directed, arginine-specific methylation of
histone H3 on a steroid-regulated promoter. Curr Biol.
11:1981–1985. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schurter BT, Koh SS, Chen D, et al:
Methylation of histone H3 by coactivator-associated arginine
methyltransferase 1. Biochemistry. 40:5747–5756. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kuhn P, Chumanov R, Wang Y, Ge Y, Burgess
RR and Xu W: Automethylation of CARM1 allows coupling of
transcription and mRNA splicing. Nucleic Acids Res. 39:2717–2726.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohkura N, Takahashi M, Yaguchi H, Nagamura
Y and Tsukada T: Coactivator-associated arginine methyltransferase
1, CARM1, affects pre-mRNA splicing in an isoform-specific manner.
J Biol Chem. 280:28927–28935. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ikeda H, Nishi S and Sakai M:
Transcription factor Nrf2/MafK regulates rat placental glutathione
S-transferase gene during hepatocarcinogenesis. Biochem J.
380:515–521. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim YR, Lee BK, Park RY, et al:
Differential CARM1 expression in prostate and colorectal cancers.
BMC Cancer. 10:1972010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hong H, Kao C, Jeng MH, et al: Aberrant
expression of CARM1, a transcriptional coactivator of androgen
receptor, in the development of prostate carcinoma and
androgen-independent status. Cancer. 101:83–89. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Majumder S, Liu Y, Ford OH III, Mohler JL
and Whang YE: Involvement of arginine methyltransferase CARM1 in
androgen receptor function and prostate cancer cell viability.
Prostate. 66:1292–1301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McMahon M, Itoh K, Yamamoto M and Hayes
JD: Keap1-dependent proteasomal degradation of transcription factor
Nrf2 contributes to the negative regulation of antioxidant response
element-driven gene expression. J Biol Chem. 278:21592–21600. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malloy MT, McIntosh DJ, Walters TS, Flores
A, Goodwin JS and Arinze IJ: Trafficking of the transcription
factor Nrf2 to promyelocytic leukemia-nuclear bodies: implications
for degradation of NRF2 in the nucleus. J Biol Chem.
288:14569–14583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kwak J, Workman JL and Lee D: The
proteasome and its regulatory roles in gene expression. Biochim
Biophys Acta. 1809:88–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Katoh Y, Itoh K, Yoshida E, Miyagishi M,
Fukamizu A and Yamamoto M: Two domains of Nrf2 cooperatively bind
CBP, a CREB binding protein, and synergistically activate
transcription. Genes Cells. 6:857–868. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niture SK and Jaiswal AK: Nrf2 protein
up-regulates antiapoptotic protein Bcl-2 and prevents cellular
apoptosis. J Biol Chem. 287:9873–9886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang CY, Mayo MW, Korneluk RG, Goeddel DV
and Baldwin AS Jr: NF-κB antiapoptosis: induction of TRAF1 and
TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.
Science. 281:1680–1683. 1998.
|
